Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals

To the editor, We have read with interest the article published in Arthritis Research & Therapy by Kushimoto et al. suggesting that the HLA-B*52 allele may indicate the presence of diffuse extracranial large vessel vasculitis (LVV) in patients with giant cell arteritis (GCA) [1]. Different studi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis research & therapy 2021-10, Vol.23 (1), p.1-268, Article 268
Hauptverfasser: Prieto-Peña, Diana, Remuzgo-Martínez, Sara, Atienza-Mateo, Belén, López-Mejias, Raquel, González-Gay, Miguel Á., Genre, Fernanda, Ocejo-Vinyals, Javier Gonzalo, Jiménez, Alejandro Muñoz, Ortiz-Sanjuán, Francisco, Romero-Yuste, Susana, Moriano, Clara, Galíndez-Agirregoikoa, Eva, Calvo, Itziar, Ortego-Centeno, Norberto, Álvarez-Rivas, Noelia, Miranda-Filloy, José A., Llorente, Irene, Blanco, Ricardo, Gualillo, Oreste, Martín, Javier, Márquez, Ana, Castañeda, Santos, Ferraz-Amaro, Iván
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To the editor, We have read with interest the article published in Arthritis Research & Therapy by Kushimoto et al. suggesting that the HLA-B*52 allele may indicate the presence of diffuse extracranial large vessel vasculitis (LVV) in patients with giant cell arteritis (GCA) [1]. Different studies point to the influence of genes located in the MHC region, in particular the HLA-DRB1*04 alleles [7]. Since the pattern of vascular involvement in Takayasu arteritis often resembles that found in patients with extracranial GCA, and the genetic contribution to the pathogenesis of the disease is mainly mediated by the HLA-B*52 allele [8], we wondered if in Caucasian individuals the association of HLA with GCA may differ according to the predominant pattern of the disease. [...]HLA-B*52 cannot be considered as a marker for extracranial LVV in Caucasian individuals over 50 years of age.
ISSN:1478-6362
1478-6354
1478-6362
DOI:10.1186/s13075-021-02659-9